{
    "clinical_study": {
        "@rank": "18290", 
        "arm_group": [
            {
                "arm_group_label": "Fish-oil emulsions", 
                "arm_group_type": "Active Comparator", 
                "description": "Preterm infants will receive a fish-oil emulsion administered from the first day of life 1gr/kg, second day 2gr/kg and third day and after 3 gr/kg."
            }, 
            {
                "arm_group_label": "soybean-oil emulsion", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Preterm infants will receive a soybean-oil emulsion administered from the first day of life 1gr/kg, second day 2gr/kg and the third day and after 3gr/kg"
            }
        ], 
        "brief_summary": {
            "textblock": "Docosahexaenoic acid (DHA) has been shown to be particularly important for fetal and\n      neonatal development. Infants born prematurely are at special risk for DHA insufficiency.\n      The source of DHA after birth for preterm babies who are not fed full enterally, are mostly\n      fat emulsions as the component of total parenteral nutrition solutions which usually do not\n      contain DHA. The aim of this study is to investigate if the fish oil emulsion-administered\n      from the first day of life and during parenteral nutrition-prevents infants from cholestasis\n      and retinopathy of prematurity."
        }, 
        "brief_title": "The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Retinopathy of Prematurity", 
            "Neonatal Cholestasis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cholestasis", 
                "Retinal Diseases", 
                "Retinopathy of Prematurity"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Infants below 32 gestational age and requiring parenteral nutrition\n\n        Exclusion Criteria:\n\n          -  Infants with congenital anomalies, infants above 32 gestational age"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "3 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875510", 
            "org_study_id": "B.10.4.\u0130SM.4.06.68.49/144"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fish-oil emulsions", 
                "description": "none", 
                "intervention_name": "fish -oil emulsions", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "soybean-oil emulsion", 
                "intervention_name": "soybean-oil emulsion", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 7, 2013", 
        "location": {
            "contact": {
                "email": "serbeken@gmail.com", 
                "last_name": "Serdar Beken, M.D", 
                "phone": "00903123056449"
            }, 
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06080"
                }, 
                "name": "Dr. Sami Ulus Childrens Hospital"
            }, 
            "investigator": {
                "last_name": "Serdar Beken, M.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Fish-oil Lipid Emulsions on Neonatal Cholestasis and Retinopathy of Prematurity", 
        "overall_contact": {
            "last_name": "Serdar Beken"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Stage of retinopathy of prematurity (I-V)", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875510"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dr. Sami Ulus Children's Hospital", 
            "investigator_full_name": "Serdar Beken", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "21199856", 
            "citation": "Pawlik D, Lauterbach R, Turyk E. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics. 2011 Feb;127(2):223-8. doi: 10.1542/peds.2010-2427. Epub 2011 Jan 3."
        }, 
        "source": "Dr. Sami Ulus Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Sami Ulus Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}